b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">30816645</PMID>\n        <DateCompleted>\n            <Year>2019</Year>\n            <Month>07</Month>\n            <Day>29</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2019</Year>\n            <Month>07</Month>\n            <Day>29</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1756-185X</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>22</Volume>\n                    <Issue>3</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>Mar</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>International journal of rheumatic diseases</Title>\n                <ISOAbbreviation>Int J Rheum Dis</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>2018 APLAR axial spondyloarthritis treatment recommendations.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>340-356</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1111/1756-185X.13510</ELocationID>\n            <Abstract>\n                <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Despite the availability of axial spondyloarthritis (SpA) recommendations proposed by various rheumatology societies, we considered that a region-specific guideline was of substantial added value to clinicians of the Asia-Pacific region, given the wide variations in predisposition to infections and other patient factors, local practice patterns, and access to treatment across countries.</AbstractText>\n                <AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Systematic reviews were undertaken of English-language articles published between 2000 and 2016, identified from MEDLINE using PubMed, EMBASE and Cochrane databases. The strength of available evidence was graded using the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) approach. Recommendations were developed through consensus using the Delphi technique.</AbstractText>\n                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Fourteen axial SpA treatment recommendations were developed based on evidence summaries and consensus. The first 2 recommendations cover non-pharmacological approaches to management. Recommendations 3 to 5 describe the following: the use of non-steroidal anti-inflammatory drugs as first-line symptomatic treatment; the avoidance of long-term corticosteroid use; and the utility of conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs) for peripheral or extra-articular manifestations. Recommendation 6 refers to the indications for biological DMARDs (bDMARDs). Recommendation 7 deals specifically with screening for infections endemic to Asia, prior to use of bDMARDs. Recommendations 7 to 13 cover the role of bDMARDs in the treatment of active axial SpA and include related issues such as continuing therapy and use in special populations. Recommendation 14 deals with the utility of surgical intervention in axial SpA.</AbstractText>\n                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">These recommendations provide up-to-date guidance for treatment of axial SpA to help meet the needs of patients and clinicians in the Asia-Pacific region.</AbstractText>\n                <CopyrightInformation>\xc2\xa9 2019 Asia Pacific League of Associations for Rheumatology and John Wiley &amp; Sons Australia, Ltd.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Tam</LastName>\n                    <ForeName>Lai Shan</ForeName>\n                    <Initials>LS</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Wei</LastName>\n                    <ForeName>James Cheng-Chung</ForeName>\n                    <Initials>JC</Initials>\n                    <Identifier Source="ORCID">https://orcid.org/0000-0002-1235-0679</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Aggarwal</LastName>\n                    <ForeName>Amita</ForeName>\n                    <Initials>A</Initials>\n                    <Identifier Source="ORCID">https://orcid.org/0000-0002-2187-5186</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Baek</LastName>\n                    <ForeName>Han Joo</ForeName>\n                    <Initials>HJ</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Rheumatology, Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Cheung</LastName>\n                    <ForeName>Peter P</ForeName>\n                    <Initials>PP</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Rheumatology, National University Hospital and Yong Loo Lin School of Medicine, National University of Singapore, Singapore City, Singapore.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Chiowchanwisawakit</LastName>\n                    <ForeName>Praveena</ForeName>\n                    <Initials>P</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Dans</LastName>\n                    <ForeName>Leonila</ForeName>\n                    <Initials>L</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pediatrics and Clinical Epidemiology, Philippine General Hospital, University of the Philippines, Manila, Philippines.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Gu</LastName>\n                    <ForeName>Jieruo</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Rheumatology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Hagino</LastName>\n                    <ForeName>Noboru</ForeName>\n                    <Initials>N</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Hematology and Rheumatology, Teikyo University Chiba Medical Center, Chiba, Japan.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Kishimoto</LastName>\n                    <ForeName>Mitsumasa</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Immuno-Rheumatology Center, St Luke`s International Hospital, St Luke`s International University, Tokyo, Japan.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Reyes</LastName>\n                    <ForeName>Heizel Manapat</ForeName>\n                    <Initials>HM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Rheumatology, Department of Medicine, Philippine General Hospital, University of the Philippines, Manila, Philippines.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Soroosh</LastName>\n                    <ForeName>Soosan</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>AJA University of Medical Sciences, Rheumatology Research Center, Tehran, Iran.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Stebbings</LastName>\n                    <ForeName>Simon</ForeName>\n                    <Initials>S</Initials>\n                    <Identifier Source="ORCID">https://orcid.org/0000-0002-2824-4440</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medicine Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Whittle</LastName>\n                    <ForeName>Samuel</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>The Queen Elizabeth Hospital, University of Adelaide, Adelaide, South Australia, Australia.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Yeap</LastName>\n                    <ForeName>Swan Sim</ForeName>\n                    <Initials>SS</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medicine, Subang Jaya Medical Centre, Subang Jaya, Malaysia.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Lau</LastName>\n                    <ForeName>Chak Sing</ForeName>\n                    <Initials>CS</Initials>\n                    <Identifier Source="ORCID">https://orcid.org/0000-0001-6698-8355</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Rheumatology and Clinical Immunology, Department of Medicine, The University of Hong Kong, Pokfulam, Hong Kong.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <GrantList CompleteYN="Y">\n                <Grant>\n                    <Agency>Asia Pacific League of Associations for Rheumatology</Agency>\n                    <Country/>\n                </Grant>\n            </GrantList>\n            <PublicationTypeList>\n                <PublicationType UI="D016446">Consensus Development Conference</PublicationType>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D017065">Practice Guideline</PublicationType>\n                <PublicationType UI="D000078182">Systematic Review</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>02</Month>\n                <Day>28</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>England</Country>\n            <MedlineTA>Int J Rheum Dis</MedlineTA>\n            <NlmUniqueID>101474930</NlmUniqueID>\n            <ISSNLinking>1756-1841</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000894">Anti-Inflammatory Agents, Non-Steroidal</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D018501">Antirheumatic Agents</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D001688">Biological Products</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CommentsCorrectionsList>\n            <CommentsCorrections RefType="CommentIn">\n                <RefSource>Int J Rheum Dis. 2019 Jul;22(7):1340-1341</RefSource>\n                <PMID Version="1">31328407</PMID>\n            </CommentsCorrections>\n        </CommentsCorrectionsList>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000305" MajorTopicYN="N">Adrenal Cortex Hormones</DescriptorName>\n                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000894" MajorTopicYN="N">Anti-Inflammatory Agents, Non-Steroidal</DescriptorName>\n                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D018501" MajorTopicYN="N">Antirheumatic Agents</DescriptorName>\n                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001208" MajorTopicYN="N" Type="Geographic">Asia</DescriptorName>\n                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001688" MajorTopicYN="N">Biological Products</DescriptorName>\n                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D032921" MajorTopicYN="N">Consensus</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D003697" MajorTopicYN="N">Delphi Technique</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D019317" MajorTopicYN="N">Evidence-Based Medicine</DescriptorName>\n                <QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D061214" MajorTopicYN="N">Patient Safety</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D012219" MajorTopicYN="N">Rheumatology</DescriptorName>\n                <QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D025241" MajorTopicYN="N">Spondylarthritis</DescriptorName>\n                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>\n                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>\n                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>\n                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">ankylosing spondylitis</Keyword>\n            <Keyword MajorTopicYN="N">axial spondyloarthritis</Keyword>\n            <Keyword MajorTopicYN="N">treatment</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>01</Month>\n                <Day>09</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>01</Month>\n                <Day>10</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>3</Month>\n                <Day>1</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>7</Month>\n                <Day>30</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>3</Month>\n                <Day>1</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">30816645</ArticleId>\n            <ArticleId IdType="doi">10.1111/1756-185X.13510</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'